AVAntonio Viayna

Antonio Viayna

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Antonio Viayna has a total of 59 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Correction: Candimine as a natural scaffold for targeting squalene synthetase in Trypanosoma cruzi: insights from computational studies

    by Antonio Viayna, Javier E. Ortiz, Frederick Schosinsky, William J. Zamora, Gabriela Egly Feresin

  • Candimine as a natural scaffold for targeting squalene synthetase in Trypanosoma cruzi: insights from computational studies

    by Antonio Viayna, Javier E. Ortiz, Frederick Schosinsky, William J. Zamora, Gabriela Egly Feresin

    Chagas disease (CD), caused by the kinetoplastid protozoan Trypanosoma cruzi, remains a major neglected tropical illness with limited therapeutic options. Natural products have historically provided structurally diverse scaffolds that serve as privileged templates in medicinal chemistry. Candimine (Cnd), an alkaloid isolated from Hippeastrum escoipense (Amaryllidaceae), has recently emerged as a promising compound with activity against T. cruzi. Although its antiparasitic effects are well documented, the precise molecular targets of Cnd have not been fully defined. The aim of this study was to perform a structure‑based molecular modeling analysis to investigate the direct interaction between candimine and key proteins essential for the survival of T. cruzi. The molecular docking and dynamics simulations revealed favorable interactions between Cnd and T. cruzi squalene synthetase (TcSQS), consistent with previously reported in vitro findings. Docking and simulation analyses showed that Cnd interacts favorably with this target, supporting a mechanism consistent with previous in vitro trypanocide activities. This is the first report to explore potential molecular mechanisms of action, offering new insights into TcSQS as a plausible target and positioning Cnd as a promising natural scaffold for developing next-generation therapies for CD.

  • Design, Synthesis, Biological Evaluation, and In Silico Analysis of Novel Antifungal Agents Targeting Trichophyton Species

    by Jorge A. Cabezas, María L. Arias, Natasha Ferllini, Yirlany Rojas, Daniel Mora, Silvana De Souza, Antonio Viayna, William J. Zamora

    Terbinafine ( Tb ) is the primary commercial treatment for superficial nail infections; however, resistance is an emerging public health concern, largely driven by point mutations in the squalene epoxidase (SQLE) gene that reduce the drug's effectiveness. In this work, five novel synthetic compounds were developed and evaluated for their antifungal activity against 24 clinical isolates of Trichophyton rubrum and Trichophyton mentagrophytes . Among them, compound antifungal 2 demonstrated potent activity at the nanomolar level (ca. 73 nM), surpassing the efficacy of Tb (ca. 253 nM), and with less risk of resistance due to its rational molecular design. Molecular docking and molecular dynamics studies, conducted using a model of fungal SQLE (SE), supported the efficacy of compound 2 as a potential antifungal agent and provided reliable structure–activity relationship insights. Our results highlight the potential of combining propiolaldehyde and sulfonamide‐based scaffolds to offer a promising foundation for the rational design of next‐generation antifungal agents.


  • Open Access

    A Multicomponent Reaction-Based Platform Opens New Avenues in Aryl Hydrocarbon Receptor Modulation

    by Pau Nadal Rodríguez, Frederick Hartung, Marina Pedrola, Seemon Coomar, Alejandro Diaz-Moreno, Anna M. Hätälä, Katharina M. Rolfes, Ismael Sánchez-Vera, Joan Gil, Elies Molins, et al.

    A multidisciplinary platform is presented to address aryl hydrocarbon receptor (AhR) modulation. A rewired Yonemitsu multicomponent reaction with indole 2-carboxaldehydes and nucleophilic species was designed to access a family of 6-substituted indolocarbazoles. The conformational behavior of these compounds was examined to rationalize their axial chirality. In silico docking and molecular simulations highlighted key features implicated in their binding to AhR. Furthermore, the synthesis of linkable derivatives allowed the direct development of conjugated entities. Reporter gene and target gene expression analyses identified these novel structures as potent noncytotoxic activating AhR ligands, that can be extended to bifunctional molecules. The anti-inflammatory properties of these AhR agonists were assessed in interleukin-13 treated keratinocytes. Altogether, the synergistic research in synthetic and computational chemistry integrated with biological studies opens novel avenues toward understanding the biological roles of AhR and the development of targeted therapeutics.


  • Open Access

    From canonical to unique: extension of a lipophilicity scale of amino acids to non-standard residues

    by Antonio Viayna, Paulina Matamoros, David Blázquez-Ruano, William J. Zamora

    Aim: The lipophilicity of amino acids plays a crucial role in delineating their physicochemical properties, offering insights into solubility, binding affinity, and bioavailability, properties th


  • Open Access

    From Canonical to Unique: Extension of A Lipophilicity Scale of Amino Acids to Non-Standard Residues

    by Antonio Viayna, Paulina Matamoros, David Blázquez-Ruano, William J. Zamora Ramírez

    The lipophilicity of amino acids plays a pivotal role in determining their physicochemical properties as it gives an estimate of solubility, binding propensity, and bioavailability. Herein, we applied the IEFPCM/MST implicit solvation model to compute the n-octanol/water partition coefficient as lipophilic descriptor for non-standard amino acids. Thus, extending our previous work on the hydrophobicity scale of amino acids. To this end, we employed two structural models, named Model 1 and 2, differentiated solely by their C-terminal capping groups using an N- or O- methyl substituent, respectively. Our findings revealed substantial similarities between the models, validating the lipophilicity values for the non-standard side chains. Differences were observed in fewer cases, indicating an effect of the capping group on the side chain hydrophobicity. This effect is expected as one model contains an hydrogen bond donor (Model 1) while the other one uses an hydrogen bond acceptor (Model 2). Overall, both models exhibit strong correlations with the experimental values, with Model 1 showing lower statistical errors. In addition, our predictions were able to correctly predict the experimental hydrophobicity change due to the number of acetylated lysines in peptide pairs determined by HPLC, suggesting that our scale can be employed for proteomics studies that include post-translational modifications beyond acetylation.


  • Identification of novel 1,2,3-triazole isatin derivatives as potent SARS-CoV-2 3CLpro inhibitors via click-chemistry-based rapid screening

    by Xiangyi Jiang, Jing Li, Antonio Viayna, F. Javier Luque, Molly Woodson, Lanlan Jing, Shenghua Gao, Fabao Zhao, Minghui Xie, Karoly Toth, et al.

    SARS-CoV-2 3-chymotrypsin-like protease (3CL pro ) is considered an attractive target for the development of anti-COVID-19 agents due to its vital function.


  • Prediction of toluene/water partition coefficients in the SAMPL9 blind challenge: assessment of machine learning and IEF-PCM/MST continuum solvation models

    by William J. Zamora, Antonio Viayna, Silvana Pinheiro, Carles Curutchet, Laia Bisbal, Rebeca Ruiz, Clara Ràfols, F. Javier Luque

    In recent years the use of partition systems other than the widely used biphasic n -octanol/water has received increased attention to gain insight into the molecular features that dictate the lipophilicity of compounds.


  • Open Access

    Prediction of Toluene/Water Partition Coefficient in the SAMPL9 Blind Challenge: Assessment of Machine Learning and IEF-PCM/MST Continuum Solvation Models

    by William J. Zamora Ramírez, Antonio Viayna, Silvana Pinheiro, Carles Curutchet, Laia Bisbal, Rebeca Ruiz, Clara Ràfols, F. Javier Luque

    In recent years the use of partition systems other than the widely used biphasic n-octanol/water has received increased attention to gain insight into the molecular features that dictate the lipophilicity of compounds. Thus, the difference between n-octanol/water and toluene/water partition coefficients has proven to be a valuable descriptor to study the propensity of molecules to form intramolecular hydrogen bonds and exhibit chameleon-like properties that modulate solubility and permeability. In this context, this study reports the experimental toluene/water partition coefficients (logPtol/w) for a series of 16 drugs that were selected as an external test set in the framework of the Statistical Assessment of the Modeling of Proteins and Ligands (SAMPL) blind challenge. This external set has been used by the computational community to calibrate their methods in the current edition (SAMPL9) of this contest. Furthermore, the study also investigates the performance of two computational strategies for the prediction of logPtol/w. The first relies on the development of two machine learning (ML) models, which are built up by combining the selection of 11 molecular descriptors in conjunction with either multiple linear regression (MLR) and random forest regression (RFR) models to target a dataset of 252 experimental logPtol/w values. The second consists of the parametrization of the IEF-PCM/MST continuum solvation model from B3LYP/6-31G(d) calculations to predict the solvation free energies of 163 compounds in toluene and benzene. The performance of the ML and IEF-PCM/MST models has been calibrated against external test sets, including the compounds that define the SAMPL9 logPtol/w challenge. The results are used to discuss the merits and weaknesses of the two computational approaches.

  • Open Access

    Three to Tango: Inhibitory Effect of Quercetin and Apigenin on Acetylcholinesterase, Amyloid-β Aggregation and Acetylcholinesterase-Amyloid Interaction

    by Irene Álvarez-Berbel, Alba Espargaró, Antonio Viayna, Ana Belén Caballero, Maria Antònia Busquets, Patrick Gámez, Francisco Javier Luque, Raimon Sabaté

    One of the pathological hallmarks of Alzheimer’s disease (AD) is the formation of amyloid-β plaques. Since acetylcholinesterase (AChE) promotes the formation of such plaques, the inhibition of this enzyme could slow down the progression of amyloid-β aggregation, hence being complementary to the palliative treatment of cholinergic decline. Antiaggregation assays performed for apigenin and quercetin, which are polyphenolic compounds that exhibit inhibitory properties against the formation of amyloid plaques, reveal distinct inhibitory effects of these compounds on Aβ40 aggregation in the presence and absence of AChE. Furthermore, the analysis of the amyloid fibers formed in the presence of these flavonoids suggests that the Aβ40 aggregates present different quaternary structures, viz., smaller molecular assemblies are generated. In agreement with a noncompetitive inhibition of AChE, molecular modeling studies indicate that these effects may be due to the binding of apigenin and quercetin at the peripheral binding site of AChE. Since apigenin and quercetin can also reduce the generation of reactive oxygen species, the data achieved suggest that multitarget catechol-type compounds may be used for the simultaneous treatment of various biological hallmarks of AD.